CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma
Clinical trial NCT04145700 · TERMINATED
Trial details
- NCT number
- NCT04145700
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-04
- Primary completion
- 2023-02-23
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.